tiprankstipranks
Advertisement
Advertisement
Kyorin Pharmaceutical Slashes Profit Outlook and Plans Dividend Cut After Sharp Earnings Decline
PremiumCompany AnnouncementsKyorin Pharmaceutical Slashes Profit Outlook and Plans Dividend Cut After Sharp Earnings Decline
3d ago
Kyorin to Transfer Generic Drug Operations to Co-Creation Platform with Daito
Premium
Company Announcements
Kyorin to Transfer Generic Drug Operations to Co-Creation Platform with Daito
18d ago
KYORIN Licenses BIODOL’s Novel Neuropathic Pain Drug for Key Asian Markets
Premium
Company Announcements
KYORIN Licenses BIODOL’s Novel Neuropathic Pain Drug for Key Asian Markets
2M ago
KYORIN Pharmaceutical Lifts Nine-Month Profit but Keeps Lower Full-Year Outlook
PremiumCompany AnnouncementsKYORIN Pharmaceutical Lifts Nine-Month Profit but Keeps Lower Full-Year Outlook
3M ago
KYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
Premium
Company Announcements
KYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
4M ago
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
Premium
Company Announcements
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
6M ago
KYORIN Pharmaceutical Announces Executive Personnel Changes
PremiumCompany AnnouncementsKYORIN Pharmaceutical Announces Executive Personnel Changes
1y ago
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
Premium
Company Announcements
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
1y ago
KYORIN Pharmaceutical Announces Special Dividend Amid Profit Surge
Premium
Company Announcements
KYORIN Pharmaceutical Announces Special Dividend Amid Profit Surge
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100